Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity

Serum response factor (SRF) is a key transcriptional activator of the c-fos gene and of muscle-specific gene expression. We have identified four forms of the SRF coding sequence, SRF-L (the previously identified form), SRF-M, SRF-S and SRF-I, that are produced by alternative splicing. The new forms of SRF lack regions of the C-terminal transactivation domain by splicing ou t of exon 5 (SRF-M), exons 4 and 5 (SRF-S) and exons 3, 4 and 5 (SRF-I). SR F-M is expressed at similar levels to SRF-L in differentiated vascular smoo th-muscle cells and skeletal-muscle cells, whereas SRF-L is the predominant form in many other tissues. SRF-S expression is restricted to vascular smo oth muscle and SRF-I expression is restricted to the embryo. Transfection o f SRF-L and SRF-M into C2C12 cells showed that both forms are transactivato rs of the promoter of the smooth-muscle-specific gene SM22 alpha, whereas S RF-I acted as a dominant negative form of SRF.